Fundamentals of cancer metabolism
Open accessThe DOI matches its Crossref record; 203 of the 204 references it cites were found in a registry or an index.
Abstract
Tumors reprogram pathways of nutrient acquisition and metabolism to meet the bioenergetic, biosynthetic, and redox demands of malignant cells. These reprogrammed activities are now recognized as hallmarks of cancer, and recent work has uncovered remarkable flexibility in the specific pathways activated by tumor cells to support these key functions. In this perspective, we provide a conceptual framework to understand how and why metabolic reprogramming occurs in tumor cells, and the mechanisms linking altered metabolism to tumorigenesis and metastasis. Understanding these concepts will progressively support the development of new strategies to treat human cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“IDH1/2 mutations have been identified in a range of tumor types, including solid tumors (e.g., gliomas and chondrosarcomas) and blood cancers like acute myelogenous leukemia (169, 170, 171).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [169]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“we propose that pharmacological ascorbate can potentially circumvent this problem by exploring two common features of cancer cells: their increased levels of labile transition metals, especially iron21, and their increased reliance on glucose uptake and glycolysis22.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“Alternatively, certain cancer cells may use carbon sources such as glutamine or acetate to compensate for the reduction in acetyl-CoA synthesis from glucose [94,95].”
From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [95]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Increased aerobic glycolysis is frequently observed in BAP1+/− cells [141], also analyzing the plasmatic metabolic profiles of individuals carrying different germline BAP1 mutations in comparison to BAP1 wild-type (BAP1WT) controls derived from two families [140].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [141]
Experimental — accuracy not yet measuredIn the citing paper
“Tumour cells exhibit a high rate of glycolysis, even in conditions with ample oxygen — a phenomenon that was first described by Otto Warburg, nearly a century ago22.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [22]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · cited 21×
“When tumor cells become nutrient-deprived, they adapt to the microenvironment by decreasing their demand for ATP.”
BackgroundInfluentialmTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509 · cited 2×
“mTORC1 is stimulated by the presence of amino acids and activates protein synthesis via its effects on translation and ribosome biogenesis (80).”
BackgroundHow mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207 · cited 1×
“ROS are intracellular chemical species that contain oxygen and include the superoxide anion (O2 ), hydrogen peroxide (H2O2), and the hydroxyl radical (OH·) (114).”
BackgroundThe emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · cited 2×
“Because some altered metabolic features are observed quite generally across many types of cancer cells, reprogrammed metabolism is considered a hallmark of cancer (1, 2).”
BackgroundIDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645 · cited 1×
“Themetabolic adaptation to hypoxia is coordinated by HIF-1, which induces metabolic genes involved in increasing glycolytic flux (23).”
Background
Cited by
Items 401–500 of 1,007
Metabolic Features of Multiple Myeloma
El Arfani, C., De Veirman, K., Maes, K., De Bruyne, E., & Menu, E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041200 · Cited by 75
“One of the processes that provide anaplerotic flux is glutaminolysis, through the generation of αKG [29].”
BackgroundLinks between cancer metabolism and cisplatin resistance
Cocetta, V., Ragazzi, E., & Montopoli, M. (2020) · International review of cytology · doi:10.1016/bs.ircmb.2020.01.005 · Cited by 80
ERK2 Phosphorylates PFAS to Mediate Posttranslational Control of De Novo Purine Synthesis
Ali, E. S., Sahu, U., Villa, E., O’Hara, B. P., Gao, P., Beaudet, C., Wood, A. W., Asara, J. M., & Ben‐Sahra, I. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.05.001 · Cited by 81
“The importance of closely linking ERK signaling to metabolism control is highlighted by the fact that aberrant regulation of this signaling pathway and cellular metabolism have been implicated in the pathophysiology of a diverse set of human diseases, including cancer and metabolic disorders (DeBerardinis and Chandel,…”
BackgroundTRPM2 promotes pancreatic cancer by PKC/MAPK pathway
Lin, R., Bao, X., Wang, H., Zhu, S., Liu, Z., Chen, Q., Ai, K., & Shi, B. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03856-9 · Cited by 82
Missiaen, R., Lesner, N. P., & Simon, M. C. (2023) · The EMBO Journal · doi:10.15252/embj.2022112067 · Cited by 83
“However, during pathological (tumor cell growth) and physiological (immune cell activation) events, metabolic needs change and these amino acids must be obtained exogenously (DeBerardinis & Chandel, 2016).”
Identification of the nicotinamide salvage pathway as a new toxification route for antimetabolites
Buonvicino, D., Mazzola, F., Zamporlini, F., Resta, F., Ranieri, G., Camaioni, E., Muzzi, M., Zecchi, R., Pieraccini, G., Dölle, C., et al. (2018) · Cell Chemical Biology · doi:10.1016/j.chembiol.2018.01.012 · Cited by 73
Understanding the Therapeutic Potential of Ascorbic Acid in the Battle to Overcome Cancer
Reang, J., Sharma, P. C., Thakur, V. K., & Majeed, J. (2021) · Biomolecules · doi:10.3390/biom11081130 · Cited by 84
“The Warburg Effect is a vital metabolic trait of cancer cells [47].”
BackgroundAlternative assembly of respiratory complex II connects energy stress to metabolic checkpoints
Bezawork‐Geleta, A., Wen, H., Dong, L., Yan, B., Vider, J., Boukalová, Š., Krobova, L., Vanova, K. H., Zobalová, R., Sobol, M. A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04603-z · Cited by 82
Targeting of peptide‐binding receptors on cancer cells with peptide‐drug conjugates
Worm, D. J., Els‐Heindl, S., & Beck‐Sickinger, A. G. (2020) · Peptide Science · doi:10.1002/pep2.24171 · Cited by 83
Reactive metabolite production is a targetable liability of glycolytic metabolism in lung cancer
Luengo, A., Abbott, K. L., Davidson, S. M., Hosios, A. M., Faubert, B., Chan, S. H., Freinkman, E., Zacharias, L. G., Mathews, T. P., Clish, C. B., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13419-4 · Cited by 82
Self-citationMetabolic reprogramming and disease progression in cancer patients
Torresano, L., Nuevo‐Tapioles, C., Santacatterina, F., & Cuezva, J. M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165721 · Cited by 76
Bekisz, S., & Geris, L. (2020) · Journal of Computational Science · doi:10.1016/j.jocs.2020.101198 · Cited by 83
Fluorescent probes for imaging bioactive species in subcellular organelles
Pramanik, S. K., & Das, A. (2021) · Chemical Communications · doi:10.1039/d1cc04273d · Cited by 73
Mazuráková, A., Koklesová, L., Csizmár, S. H., Samec, M., Brockmueller, A., Šudomová, M., Biringer, K., Kúdela, E., Péč, M. J., Samuel, S. M., et al. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.02.015 · Cited by 78
Mitochondrial fatty acid oxidation drives senescence
Yamauchi, S., Sugiura, Y., Yamaguchi, J., Zhou, X., Takenaka, S., Odawara, T., Fukaya, S., Fujisawa, T., Naguro, I., Uchiyama, Y., et al. (2024) · Science Advances · doi:10.1126/sciadv.ado5887 · Cited by 84
Uo, T., Sprenger, C. C. T., & Plymate, S. R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.580617 · Cited by 88
“Therapeutic targets in cancer metabolism in many cases exist even in the normal cells, which adds potential toxicity and nonspecificity to drugs targeting metabolic pathways (162).”
BackgroundHuang, X. Y., Hou, Y., Weng, X., Pang, W., Hou, L., Liang, Y., Wang, Y., Du, L., Wu, T., Yao, M., et al. (2021) · Oncogenesis · doi:10.1038/s41389-020-00295-7 · Cited by 80
Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2
Sun, T., Liu, Z., Bi, F., & Yang, Q. F. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13076 · Cited by 78
Deregulated transcription factors in cancer cell metabolisms and reprogramming
Kant, R., Manne, R., Anas, M., Penugurti, V., Chen, T., Pan, B., Hsu, C.-C., & Lin, H. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.10.001 · Cited by 81
FBXO7 ubiquitinates PRMT1 to suppress serine synthesis and tumor growth in hepatocellular carcinoma
Luo, L., Wu, X., Fan, J., Dong, L., Wang, M., Zeng, Y., Li, S., Yang, W., Jiang, J., & Wang, K. (2024) · Nature Communications · doi:10.1038/s41467-024-49087-2 · Cited by 81
L- and D-Lactate: unveiling their hidden functions in disease and health
Li, J., Ma, P., Liu, Z., & Xie, J. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02132-z · Cited by 85
“Importantly, compared with anaerobic glycolysis, aerobic glycolysis relies on distinct molecular mechanisms [19, 20]; distinguishing between these two metabolic states provides critical insight into the metabolic adaptability of cancer cells and highlights the importance of targeting specific…”
Lee, B., Mahmud, I., Marchica, J., Dereziński, P., Qi, F., Wang, F., Joshi, P. K., Valerio, F., Rivera, I., Patel, V., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-60616-z · Cited by 75
Geck, R. C., Foley, J. R., Stewart, T. M., Asara, J. M., Casero, R. A., & Toker, A. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012376 · Cited by 80
“In the past two decades, a renewed interest in tumor metabolism has led to the identification of novel therapeutic vulnerabilities in a variety of cancers (1, 2).”
BackgroundHe, L., Li, H., Pan, C., Hua, Y., Peng, J., Zhou, Z., Zhao, Y., & Lin, M. (2021) · 癌症:英文版 · doi:10.1002/cac2.12187 · Cited by 71
Li, M., Hao, B., Zhang, M., Reiter, R. J., Lin, S., Zheng, T., Chen, X., Ren, Y., Yue, L., Abay, B., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00745-7 · Cited by 72
“Tumorigenesis is a complex process that involves multi-signal pathways.(43) And RFA+MLT treatment caused upregulated expression of lipid metabolism, DNA repair pathways, cell cycle, and mitotic checkpoints (G2M, E2F target), which suggest that the tumors were adjusted to a lower malignancy.”
BackgroundFunctional Role of Mitochondrial DNA in Cancer Progression
Lin, Y.-H., Lim, S.-N., Chen, C.-Y., Chi, H.-C., Yeh, C.-T., & Lin, W.-R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031659 · Cited by 70
“In fact, tumor cells can reprogram bioenergetic signal transduction, such as glucose metabolism and ROS production, to support survival [14,15].”
BackgroundSadeghi, M., Kashanian, S., Naghib, S. M., Askari, E., Haghiralsadat, F., & Tofighi, D. (2022) · Nanotechnology Reviews · doi:10.1515/ntrev-2022-0047 · Cited by 70
“Cancer is an intricate morbidity that causes drastic changes in the levels of genes, proteins, andmetabolites [1,2].”
BackgroundLee, Y. G., Nam, Y., Shin, K. J., Yoon, S., Park, W. S., Joung, J. Y., Seo, J. K., Jang, J., Lee, S., Nam, D., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.12.017 · Cited by 73
Pham, D., & Park, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031444 · Cited by 79
“Furthermore, metabolic plasticity supports the survival of cancer cells under unfavorable conditions, such as oxidative stress, acidification, hypoxia, and nutrient depletion, which might be indispensable for tumor progression and metastasis [12].”
BackgroundInfluentialMucin1 and Mucin16: Therapeutic Targets for Cancer Therapy
Lee, D.-H., Choi, S., Park, Y., & Jin, H. (2021) · Pharmaceuticals · doi:10.3390/ph14101053 · Cited by 78
Carvalho, T. M. A., Molfetta, D. D., Greco, M. R., Koltai, T., Alfarouk, K. O., Reshkin, S. J., & Cardone, R. A. (2021) · Cancers · doi:10.3390/cancers13236135 · Cited by 83
“Interestingly, both extrude protons against the gradient; however, while proton pum s need energy (ATP) for their activity, NHE1 does not need ATP to achieve the same purpose.”
BackgroundInfluentialShim, J., Choi, S., Yoon, S., Choi, R. J., Park, J., Lee, E. H., Cho, H. J., Lee, S., Teo, W., Moon, J. H., et al. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02731-7 · Cited by 75
“Recent studies have shown that numerous metabolic pathways are upregulated together in cancer [36, 37].”
BackgroundHoerner, C. R., Chen, V. J., & Fan, A. C. (2019) · Kidney Cancer · doi:10.3233/kca-180043 · Cited by 68
The Role of Antioxidants in Cancer, Friends or Foes?
Poljsak, B., & Milisav, I. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190123112647 · Cited by 67
Lee, J., Oh, S. J., Choi, H.-J., Kang, J. H., Lee, S.-H., Ha, J. S., Woo, S. M., Jang, H., Lee, H., & Kim, S. (2020) · Cancers · doi:10.3390/cancers12092477 · Cited by 78
“However, the mitochondria of cancer cells are intact as well as the respiratory rate of cancer cells is higher than that of normal cells [5,6].”
BackgroundTGF-β in Cancer: Metabolic Driver of the Tolerogenic Crosstalk in the Tumor Microenvironment
Angioni, R., Sánchez‐Rodríguez, R., Viola, A., & Molon, B. (2021) · Cancers · doi:10.3390/cancers13030401 · Cited by 78
“in oxidative metabolism, consistent evidence later on showed that a tumoral metabolic reprogramming is responsible for an increase of glucose metabolism despite an intact respiratory chain activity [4].”
BackgroundInhibition of the mitochondrial protein Opa1 curtails breast cancer growth
Zamberlan, M., Boeckx, A., Muller, F., Vinelli, F., Ek, O., Vianello, C., Coart, E., Shibata, K., Christian, A., Grespi, F., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02304-6 · Cited by 77
Obesity and Cancer Metabolism: A Perspective on Interacting Tumor–Intrinsic and Extrinsic Factors
Doerstling, S. S., O’Flanagan, C. H., & Hursting, S. D. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00216 · Cited by 68
“Nat Rev Clin Oncol (2012) 9(5):259–67.”
BackgroundInfluentialStrategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma
Hargadon, K. M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01594 · Cited by 67
Savino, A. M., Fernandes, S. I., Olivares, O., Zemlyansky, A., Cousins, A., Markert, E. K., Barel, S., Geron, I., Frishman‐Levy, L., Birger, Y., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-00115-2 · Cited by 74
Oncogene-regulated release of extracellular vesicles
Kilinc, S., Paisner, R., Camarda, R., Gupta, S., Momčilović, O., Kohnz, R. A., Avşaroğlu, B., L’Étoile, N. D., Perera, R. M., Nomura, D. K., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.05.014 · Cited by 75
Burns, J. E., Hurst, C. D., Knowles, M. A., Phillips, R. M., & Allison, S. J. (2021) · Cancer Science · doi:10.1111/cas.15047 · Cited by 82
Radiotherapy-induced metabolic hallmarks in the tumor microenvironment
Mittal, A., Nenwani, M., Sarangi, I., Achreja, A., Lawrence, T. S., & Nagrath, D. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.05.005 · Cited by 84
Noninvasive detection of any-stage cancer using free glycosaminoglycans
Bratulić, S., Limeta, A., Dabestani, S., Birgisson, H., Enblad, G., Stålberg, K., Hesselager, G., Häggman, M., Höglund, M., Simonson, O. E., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2115328119 · Cited by 72
“Instead of genomics and proteomics, we investigated cancer metabolism as an identifiable cancer hallmark that could fill the information gap of current liquid biopsy platforms (14, 15).”
BackgroundResultChoudhury, S., Narayanan, B., Moret, M., Hatzimanikatis, V., & Miskovic, L. (2024) · Nature Catalysis · doi:10.1038/s41929-024-01220-6 · Cited by 67
“They belong to the following metabolic subsystems: i) Pyruvate metabolism (9), ii) Citric acid cycle (17), iii) Nucleotide salvage pathway (3), iv) Tyrosine, Tryptophan and Phenylalanine metabolism (22), v) Glycolsis (14), vi) Glutamate metabolism (6), vii) Pentose phosphate pathway (11), viii) Anaplerotic reactions (…”
BackgroundmiR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer
Barisciano, G., Colangelo, T., Rosato, V., Muccillo, L., Taddei, M. L., Ippolito, L., Chiarugi, P., Galgani, M., Bruzzaniti, S., Matarese, G., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0773-2 · Cited by 70
Isotope tracing in adult zebrafish reveals alanine cycling between melanoma and liver
Naser, F. J., Jackstadt, M. M., Fowle-Grider, R., Spalding, J. L., Cho, K., Stancliffe, E., Doonan, S. R., Kramer, E. T., Yao, L., Krasnick, B. A., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.04.014 · Cited by 74
Exploiting cancer’s drinking problem: regulation and therapeutic potential of macropinocytosis
Puccini, J., Badgley, M. A., & Bar‐Sagi, D. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.09.004 · Cited by 71
Role of Branched-chain Amino Acid Metabolism in Tumor Development and Progression
Jung, M. K., Okekunle, A. P., Lee, J. E., Sung, M. K., & Lim, Y. J. (2021) · Journal of Cancer Prevention · doi:10.15430/jcp.2021.26.4.237 · Cited by 74
“Tumor cells often potentially undergo uncontrolled and unlimited evolution which is dependent on the availability of some metabolites in the context of tumor microcosm for survival [1,2].”
BackgroundThe development of small-molecule inhibitors targeting hexokinase 2
Shan, W., Zhou, Y., & Tam, K. Y. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.05.017 · Cited by 73
Zhao, L., Rao, X., Zheng, R., Huang, C., Kong, R., Cheng, H. B., Li, B., & Li, S. (2023) · Nano Letters · doi:10.1021/acs.nanolett.3c01812 · Cited by 69
Liu, N., Yan, M., Tao, Q., Wu, J., Chen, J., Chen, X., & Peng, C. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007146 · Cited by 73
Intermittent hypoxia and cancer: Undesirable bed partners?
Almendros, I., & Gozal, D. (2017) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2017.08.008 · Cited by 72
Mapping and Profiling Lipid Distribution in a 3D Model of Breast Cancer Progression
Vidavsky, N., Kunitake, J. A. M. R., Diaz-Rubio, M. E., Chiou, A. E., Loh, H.-C., Zhang, S., Mašić, A., Fischbach, C., & Estroff, L. A. (2019) · ACS Central Science · doi:10.1021/acscentsci.8b00932 · Cited by 64
Liu, D., Badeti, S., Dotti, G., Jiang, J.-G., Wang, H., Dermody, J. J., Soteropoulos, P., Streck, D. L., Birge, R. B., & Liu, C. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00617-7 · Cited by 74
“Cancer cells are highly metabolically active and have relatively high amounts of glycolysis and glutaminolysis [144].”
BackgroundMutation–selection balance and compensatory mechanisms in tumour evolution
Persi, E., Wolf, Y. I., Horn, D., Ruppin, E., Demichelis, F., Gatenby, R. A., Gillies, R. J., & Koonin, E. V. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-020-00299-4 · Cited by 68
Xiao, Y., Chen, P., Lei, S., Bai, F., Fu, L., Lin, J., & Huang, P. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202204584 · Cited by 68
Deregulation of SPOP in Cancer
Zhang, H., Jin, X., & Huang, H. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-2801 · Cited by 71
Vangapandu, H. V., Alston, B., Morse, J., Ayres, M., Wierda, W. G., Keating, M. J., Marszalek, J. R., & Gandhi, V. V. (2018) · Oncotarget · doi:10.18632/oncotarget.25166 · Cited by 72
“In contrast to this common view of metabolic switch, newer studies suggest that both glycolysis and oxidative phosphorylation are enhanced in tumor tissue compared with surrounding cells [27].”
BackgroundYin Yang 1 promotes the Warburg effect and tumorigenesis via glucose transporter GLUT3
Wang, Y., Wu, S., Huang, C., Li, Y., Zhao, H., & Kasim, V. (2018) · Cancer Science · doi:10.1111/cas.13662 · Cited by 72
“Meanwhile, glycolysis supports the high proliferation rate of tumor cells.(2,27) Thus, we next tested whether GLUT3 is involved in YY1‐induced tumor cell proliferation.”
BackgroundmiR-450a Acts as a Tumor Suppressor in Ovarian Cancer by Regulating Energy Metabolism
Muys, B. R., Sousa, J. F., Plaça, J. R., de Araújo, L. F., Sarshad, A. A., Anastasakis, D. G., Wang, X., Li, X. L., de Molfetta, G. A., Ramão, A., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0490 · Cited by 68
“A prominent miR-450a-target was ACO2, which is part of the citric acid cycle and metabolizes α-ketoglutarate, a product of glutamine oxidation (35).”
BackgroundKrstic, J., Reinisch, I., Schindlmaier, K., Galhuber, M., Riahi, Z., Berger, N., Kupper, N., Moyschewitz, E., Auer, M., Michenthaler, H., et al. (2022) · Science Advances · doi:10.1126/sciadv.abh2635 · Cited by 67
“The rationale underlying the use of fasting in cancer therapy is based on specific and general features of cancer cells: They disobey antigrowth signals ( 7 ) and have a pronounced anabolic appetite ( 8 , 9 ).”
Deciphering metabolic rewiring in breast cancer subtypes
Ogrodzinski, M. P., Bernard, J. J., & Lunt, S. Y. (2017) · Translational research · doi:10.1016/j.trsl.2017.07.004 · Cited by 73
“Signaling pathways that impact cancer metabolism include phosphatidylinositol 3-kinase (PI3K), protein kinase B (Akt), mammalian target of rapamycin (mTOR), hypoxia-inducible factor-1 (HIF-1), sterol regulatory element binding protein, c-Myc, Kras, and p53.(8) Interestingly, several of these signaling pathways are in…”
BackgroundWaste Not, Want Not: Lactate Oxidation Fuels the TCA Cycle
Martínez‐Reyes, I., & Chandel, N. S. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.005 · Cited by 69
“Tumors require metabolic rewiring to efficiently utilize nutrients needed to support uncontrolled cell proliferation (DeBerardinis and Chandel, 2016).”
BackgroundSelf-citationTan, J. L., Li, F., Yeo, J. Z., Yong, K. J., Bassal, M. A., Ng, G. H., Lee, M. Y., Leong, C. Y., Tan, H. K., Wu, C.-S., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.08.022 · Cited by 64
A pH‐Responsive Polymer‐CeO2 Hybrid to Catalytically Generate Oxidative Stress for Tumor Therapy
Tian, Z., Liu, H., Guo, Z., Gou, W., Liang, Z., Qu, Y., Han, L., & Liu, L. (2020) · Small · doi:10.1002/smll.202004654 · Cited by 64
Albrecht, L. V., Bui, M. H., & Robertis, E. M. D. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820161116 · Cited by 68
On the energy efficiency of cell migration in diverse physical environments
Li, Y., Yao, L., Mori, Y., & Sun, S. X. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1907625116 · Cited by 65
“Therefore, the 2-phase mechanical framework presented here has general implications for cell motility (3, 8, 9) and provides a physical basis for understanding forces and energetics during tissue morphogenesis and cell movement.”
The Translational Status of Cancer Liquid Biopsies
Bratulić, S., Gatto, F., & Nielsen, J. (2019) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-019-00141-2 · Cited by 70
Li, C., You, X., Xu, X., Wu, B., Liu, Y., Tong, T., Chen, J., Li, Y., Dai, C., Ye, Z., et al. (2022) · Advanced Science · doi:10.1002/advs.202104134 · Cited by 64
Li, D., Zhang, T., Guo, Y., Bi, C., Liu, M., & Wang, G. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06888-z · Cited by 74
“Although the ef fi cacy of glycolysis in ATP generation is low and under question, but it brings immediate energy and nutrients for tumor growth [103 – 105].”
BackgroundRinaldi, G., Rossi, M., & Fendt, S. (2018) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1397 · Cited by 63
Recent advances in cancer metabolism: a technological perspective
Kang, Y. P., Ward, N. P., & DeNicola, G. M. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0027-z · Cited by 74
Hill, B. G., Shiva, S., Ballinger, S. W., Zhang, J., & Darley-Usmar, V. M. (2019) · Biological Chemistry · doi:10.1515/hsz-2019-0268 · Cited by 69
“…most to the core metabolic functions that support proliferation; however, recent studies indicate that other substrates, including branched chain amino acids (BCAAs), lactate, serine and glycine, also provide material resources required for replication (White, 2013; DeBerardinis and Chandel, 2016).”
BackgroundMetabolic Dysregulations and Epigenetics: A Bidirectional Interplay that Drives Tumor Progression
Crispo, F., Condelli, V., Lepore, S., Notarangelo, T., Sgambato, A., Esposito, F., Maddalena, F., & Landriscina, M. (2019) · Cells · doi:10.3390/cells8080798 · Cited by 67
“Also, many pieces of evidence suggest that the interplay between epigenetic mechanisms and metabolic changes is bidirectional [2,4,21,22].”
BackgroundMetabolic reprogramming sustains cancer cell survival following extracellular matrix detachment
Endo, H., Owada, S., Inagaki, Y., Shida, Y., & Tatemichi, M. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101643 · Cited by 62
“cancer cells, metabolic reprogramming is considered a hallmark of cancer [10,11].”
BackgroundRoles of the BAP1 Tumor Suppressor in Cell Metabolism
Han, A., Purwin, T. J., & Aplin, A. E. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3430 · Cited by 70
“Studies have demonstrated that oncogene activation and/or tumor suppressor gene inactivation alter cancer cellmetabolism for tumor formation and progression (8, 9).”
BackgroundLakshmanachetty, S., Cruz, J. C., Hoffmeyer, E., Cole, A. P., & Mitra, S. S. (2021) · Cells · doi:10.3390/cells10040893 · Cited by 69
“To this end, they preferentially utilize glycolysis, amino acid metabolism, pentosephosphate pathway (PPP), and tricarboxylic acid (TCA) cycle to thrive under the harsh environmental conditions presented by the TME [51].”
BackgroundSystems-based approaches to study immunometabolism
Purohit, V., Wagner, A., Yosef, N., & Kuchroo, V. K. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00783-9 · Cited by 68
“Metabolism ful fi lls three basic needs of an organism, i.e., the generation of energy in the form of ATP, the maintenance of redox potential by the generation of NAD(P)H, and the synthesis of macromolecules [15, 16].”
BackgroundLiu, J., Shen, H., Gu, W., Zheng, H., Wang, Y., Ma, G., & Du, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.960738 · Cited by 71
“In this harsh TME, infiltrating immune cells are forced to undergo relevant metabolic adaptations, which in turn disrupt the antitumor effects of immune cells (6, 7).”
BackgroundMGMT in TMZ-based glioma therapy: Multifaceted insights and clinical trial perspectives
Shaw, R., Basu, M., Karmakar, S., & Ghosh, M. K. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119673 · Cited by 73
Corsetti, G., Pasini, E., Scarabelli, T. M., Romano, C., Singh, A., Scarabelli, C. C.-S. I. T. M., & Dioguardi, F. S. (2024) · Nutrients · doi:10.3390/nu16152417 · Cited by 79
“The characterization of metabolic reprogramming in the tumor microenvironment is becoming increasingly crucial in cancer research and patient care [95].”
BackgroundWang, H., Xu, M., Zhang, T., Pan, J., Li, C., Pan, B., Zhou, L., Huang, Y., Gao, C., He, M., et al. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.70045 · Cited by 76
“7,9,28 In addition to vigorous metabolism, the expression of many metabolic enzymes increases abnormally.”
BackgroundRecent Developments in Single-Cell Metabolomics by Mass Spectrometry─A Perspective
Petrova, B., & Güler, A. T. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00646 · Cited by 77
Hlouschek, J., Ritter, V., Wirsdörfer, F., Klein, D., Jendrossek, V., & Matschke, J. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.09.002 · Cited by 69
Wang, X., Lin, Y., Kemper, T., Chen, J., Yuan, Z., Liu, S., Zhu, Y., Broering, R., & Lu, M. (2019) · Cellular Microbiology · doi:10.1111/cmi.13131 · Cited by 62
“Glucose 6‐ phosphate may enter various metabolic pathways, including glycolysis, glycogen synthesis, the hexosamine pathway, the pentose phosphate pathway, and oxidative routes (DeBerardinis & Chandel, 2016).”
BackgroundKhan, M. A., Zubair, H., Anand, S., Srivastava, S. K., Singh, S., & Singh, A. P. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.01.003 · Cited by 62
Yi, K., Zhan, Q., Wang, Q., Tan, Y., Fang, C., Wang, Y., Zhou, J., Yang, C., Li, Y., & Kang, C. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa255 · Cited by 64
A new role for extracellular vesicles: how small vesicles can feed tumors' big appetite
Lazar, I., Clement, E., Attané, C., Muller, C., & Nieto, L. (2018) · Journal of Lipid Research · doi:10.1194/jlr.r083725 · Cited by 65
Lewis, J. E., Forshaw, T. E., Boothman, D. A., Furdui, C. M., & Kemp, M. L. (2021) · Cell Systems · doi:10.1016/j.cels.2020.12.001 · Cited by 61
Cancer metabolism and intervention therapy
Zhao, H., & Li, Y. (2021) · Molecular Biomedicine · doi:10.1186/s43556-020-00012-1 · Cited by 74
Metabolomic biomarkers of pancreatic cancer: a meta-analysis study
Mehta, K. Y., Wu, H.-J., Menon, S. S., Fallah, Y., Zhong, X., Rizk, N. M., Unger, K. R., Mapstone, M. E., Fiandaca, M. S., Federoff, H. J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20324 · Cited by 69
“Several signaling pathways that are altered during carcinogenesis are known to impact metabolic processes [71].”
BackgroundPérez-Arnáiz, C., Acuña, M. I., Busto, N., Echevarría, I., Martínez-Alonso, M., Espino, G., García, B., & Domínguez, F. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.07.065 · Cited by 65
Du, S., Wang, Y., Alatrash, N., Weatherly, C. A., Roy, D., MacDonnell, F. M., & Armstrong, D. W. (2018) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2018.10.047 · Cited by 67
NF-κB and mitochondria cross paths in cancer: mitochondrial metabolism and beyond
Capece, D., Verzella, D., Francesco, B. D., Alesse, E., Franzoso, G., & Zazzeroni, F. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.021 · Cited by 69
Wang, C., Xu, J., Yuan, D., Bai, Y., Pan, Y., Zhang, J., & Shao, C. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03729-3 · Cited by 66
The Role of Hyperglycemia in Endometrial Cancer Pathogenesis
Byrne, F. L., Martin, A. R., Kosasih, M., Caruana, B. T., & Farrell, R. (2020) · Cancers · doi:10.3390/cancers12051191 · Cited by 71
“Many of the somatic drivers of EC development in some way or another regulate cell metabolism [6,8,70].”
BackgroundAPC loss induces Warburg effect via increased PKM2 transcription in colorectal cancer
Cha, P.-H., Hwang, J., Kwak, D.-K., Koh, E., Kim, K., & Choi, K. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01118-7 · Cited by 67
Morris, O., Deng, H., Tam, C., & Jasper, H. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108423 · Cited by 62
Jiang, Q., Pan, M., Hu, J., Sun, J., Fan, L., Zou, Z., Wei, J., Yang, X., & Liu, X. (2020) · Chemical Science · doi:10.1039/d0sc04983b · Cited by 61
Metadata
- Authors
- DeBerardinis, R. J., & Chandel, N. S.
- Affiliations
- Children's Medical Center (US)
- Northwestern University (US)
- Corresponding author
- DeBerardinis, Ralph J.
- Chandel, Navdeep S.
- Venue
- Science Advances
- Published
- 2016-05-06
- Volume
- 2
- Issue
- 5
- Pages
- e1600200-e1600200
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC4928883
- OpenAlex
- W2395626624
- Semantic Scholar
- bebecd5b21653ab07940aa17ec319c54e710f9dc
- Cited by
- 3,013
- References
- 204
- Citations by year
- 2026: 271 · 2025: 296 · 2024: 326 · 2023: 359 · 2022: 427 · 2021: 447 · 2020: 340 · 2019: 257 · 2018: 166 · 2017: 109 · 2016: 12
- FWCI
- 16.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (ID0E1EAG7327, R01 CA123067)
- National Cancer Institute (ID0EAMAG7328, 5R01CA157996)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- cancer metabolism, metabolic reprogramming, tumor bioenergetics, redox metabolism, nutrient acquisition, carcinogenesis, metastasis, cancer therapy
- MeSH terms
- Animals, Energy Metabolism, Humans, Mitochondria, Neoplasms, Oxidation-Reduction, Signal Transduction, Reactive Oxygen Species, Macromolecular Substances, Metabolic Networks and Pathways, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.